| |
| |
|
| Insider
Information: |
Stover Jack E |
| Relationship: |
Officer, Director, 10%... |
| City: |
Exton |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
394,672 |
|
|
Indirect Shares
|
4,743,750 |
|
|
| Direct
Value |
$1,624,846 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
5,138,422 |
|
|
| Total
Value |
$1,624,846 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antares Pharma Inc |
ATRS |
President and CEO, Dir... |
2008-05-14 |
276,666 |
2004-07-22 |
0 |
Premium* |
|
|
Interpace Biosciences Inc |
IDXG |
President and CEO, Dir... |
2020-03-12 |
30,271 |
2006-06-06 |
0 |
Premium* |
|
|
Arbios Systems Inc |
ARBI |
Director |
2007-07-12 |
40,625 |
2006-09-15 |
0 |
Premium* |
|
|
Onconova Therapeutics, Inc. |
ONTX |
Director |
2018-04-27 |
47,110 |
|
0 |
Premium* |
|
|
Northview Acquisition Corp |
NVAC |
Officer, Director, 10%... |
|
0 |
2021-12-20 |
4,743,750 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAC |
Northview Acquisition Cor... |
Chief Executive OfficerOfficer |
• • • |
2021-12-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,743,750 |
|
- |
|
| IDXG |
Interpace Biosciences Inc |
President and CEO |
• • – |
2020-03-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,188 |
30,271 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
President and CEO |
• • – |
2019-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
86,922 |
427,300 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
President and CEO |
• • – |
2018-12-05 |
4/A |
A |
$0.00 |
$0 |
D/D |
87,000 |
340,378 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
President and CEO |
• • – |
2018-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
313,378 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
Director |
– • – |
2018-04-27 |
4 |
B |
$0.00 |
$0 |
D/D |
47,100 |
47,110 |
2.31 |
- |
|
| IDXG |
Interpace Biosciences Inc |
President and CEO |
• • – |
2018-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
56,000 |
75,738 |
0 |
- |
|
| ONTX |
Onconova Therapeutics, In... |
Director |
– • – |
2016-06-30 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
10 |
|
- |
|
| IDXG |
Interpace Biosciences Inc |
Interim President and CEO |
• • – |
2016-02-03 |
4 |
A |
$0.53 |
$53,000 |
D/D |
100,000 |
197,378 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2015-06-03 |
4 |
A |
$1.32 |
$45,000 |
D/D |
34,091 |
97,378 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2014-06-04 |
4 |
A |
$4.52 |
$45,001 |
D/D |
9,956 |
63,287 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2013-06-04 |
4 |
A |
$4.47 |
$45,004 |
D/D |
10,068 |
53,331 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2012-06-05 |
4 |
A |
$8.07 |
$45,006 |
D/D |
5,577 |
43,263 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2011-05-31 |
4 |
A |
$6.90 |
$45,002 |
D/D |
6,522 |
37,686 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2010-06-03 |
4 |
A |
$7.91 |
$45,000 |
D/D |
5,689 |
31,164 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2009-06-04 |
4 |
A |
$3.67 |
$45,002 |
D/D |
12,262 |
25,475 |
0 |
- |
|
| ATRS |
Antares Pharma Inc |
President and CEO |
• • – |
2008-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
60,000 |
276,666 |
0 |
- |
|
| ARBI |
Arbios Systems Inc |
Director |
– • – |
2007-07-12 |
4 |
A |
$0.00 |
$0 |
D/D |
40,625 |
40,625 |
0 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2007-06-05 |
4 |
A |
$10.20 |
$44,992 |
D/D |
4,411 |
7,658 |
0 |
- |
|
| ARBI |
Arbios Systems Inc |
Director |
– • – |
2006-11-09 |
4 |
A |
$0.00 |
$0 |
D/D |
26,563 |
26,563 |
0 |
- |
|
| ARBI |
Arbios Systems Inc |
Director |
– • – |
2006-09-15 |
4 |
B |
$0.70 |
$700 |
D/D |
1,000 |
1,000 |
2.31 |
- |
|
| IDXG |
Interpace Biosciences Inc |
Director |
– • – |
2006-06-06 |
4 |
A |
$13.86 |
$45,003 |
D/D |
3,247 |
3,247 |
|
- |
|
| ATRS |
Antares Pharma Inc |
President/CEO |
• • – |
2006-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
86,666 |
486,035 |
|
- |
|
| ATRS |
Antares Pharma Inc |
President/CEO |
• – – |
2005-03-30 |
4 |
A |
$0.98 |
$4,900 |
D/D |
5,000 |
255,572 |
|
- |
|
| ATRS |
Antares Pharma Inc |
President/COOOfficer |
• – – |
2004-07-22 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
30,000 |
|
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
